Commercial Strategy for Regulated & Complex-Decision Industries
You don't need a full-time Commercial Director. You need someone who's already been one.
Fractional go-to-market, launch, and portfolio strategy for biotech, medtech, and specialty pharma teams navigating payers, tenders, and multi-stakeholder launches — built by someone who's carried the risk, not just advised on it.
New: Go-to-Market Decision System — Core Edition
A 5-stage decision framework for GTM strategy, now available.
New: Brand Positioning Decision System
An 8-stage decision system for brand positioning, now available.
Your launch plan can't afford to be a guess.
You're staring down a launch, a portfolio decision, or a payer negotiation that will define the next three years of revenue — and you're doing it with a team that's stretched too thin to build it properly.
Hire a big consultancy, and you'll pay six figures for a deck built by someone who's never sat across the table from a tender board. Hire a generalist marketer, and you'll get consumer-brand thinking applied to a decision that actually runs through Medical, Regulatory, Finance, and a Ministry of Health.
This isn't a marketing problem. It's a high-stakes, cross-functional, multi-stakeholder commercial problem — and it needs someone who's solved it before, at scale, when the numbers were real.
Strategic clarity for every stage of growth.
Whether you're entering a new market, sequencing a portfolio, or preparing a launch for leadership review — I bring the commercial rigor to move you forward with confidence.
Go-to-Market & Launch Strategy
Precise, executable launch plans for regulated healthcare markets — from segmentation and positioning to phased roadmaps with measurable KPIs.
Competitive & Market Intelligence
Rigorous market and competitive analysis to validate assumptions, size opportunities, and inform high-stakes commercial decisions.
Portfolio Optimization & Lifecycle Strategy
Sequencing decisions across a multi-product portfolio — what launches first, what gets deprioritized, and how new entrants compete without cannibalizing existing revenue.
Cross-Functional Commercial Facilitation
Coming in as the translator between Medical, Regulatory, Finance, and Supply Chain when a launch plan needs buy-in from all four and currently has it from none.
Engagement Formats
Strategic Sprint
1–3 weeks
Fractional Advisory
Monthly
Board / Investor Strategy Narrative
Project-based
This isn't theoretical.
USD 300M+
Revenue generated via national immunization program inclusion
600+
Sites coordinated in a national vaccine rollout
20%
Additional treatment budget secured in a biosimilar-to-innovator Ministry of Health negotiation
15+ yrs
Commercial leadership across regulated healthcare markets — spanning Latin America, Asia, and the Middle East
A defined path from decision to deliverable.
- 01Free, 30 min
Strategy Call
We diagnose the actual decision you're facing and whether this is the right fit.
- 02Fixed price
Scoped Proposal
Fixed-scope, fixed-price proposal for a defined deliverable — no open-ended hourly billing on strategic work.
- 03Structured
Build & Check-ins
Working sessions so you're never surprised by the output.
- 04Board-ready
Delivery + Walkthrough
A document built to survive a leadership or board review, plus a live walkthrough.
Not another deck.
- 01
I've owned the outcome, not just advised on it.
Fifteen years carrying commercial P&L responsibility across global and regional roles — not a career built inside a consultancy deck.
- 02
I speak every function's language.
Medical, Regulatory, Finance, Supply Chain, Market Access — I've sat in each room and can build a plan all four will actually sign off on.
- 03
You get me, not a bench.
No junior team assembling frameworks in the background. The person you scope with is the person doing the work.
- 04
Built for regulated, multi-stakeholder markets.
This isn't consumer marketing repackaged. It's commercial strategy designed for payers, tender boards, Ministries of Health and KOL-driven decisions.
Questions, answered directly.
No — this applies to any regulated or complex-decision industry where the buyer isn't a single consumer: biotech, medtech, health tech, and adjacent regulated sectors.
Yes — happy to sign an NDA before any confidential details are shared.
That's exactly what the strategic sprint format is for.
Fixed-scope pricing for defined deliverables, or a monthly retainer for ongoing fractional advisory.
Ready to build a sharper commercial strategy?
Book a free 30-minute strategy call. If it's not the right fit, I'll tell you directly — and point you toward what would be.